Joint Department of Physics, Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom.
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):1006-12. doi: 10.1016/j.ijrobp.2010.12.033. Epub 2011 Feb 23.
To develop and compare a volumetric modulated arc therapy (VMAT) technique with conventional radiotherapy for craniospinal irradiation with respect to improved dose conformity and homogeneity in the planning target volume (PTV) and to reduced dose to organs at risk (OAR).
Conventional craniospinal axis radiotherapy plans of 5 patients were acquired. The median (range) length of the PTV was 58.9 (48.1-83.7) cm. The 6-MV VMAT plans were inversely planned with one isocenter near the base of the brain and the minimum number of isocenters required for the specified lengths of spine. The plans were optimized with high weighting for PTV coverage and low weighting for OAR sparing. Conformity and heterogeneity indices, dose-volume histograms, mean doses, and non-PTV integral doses from the two plans (prescription dose 23.4 Gy in 13 fractions) were compared.
The median (range) conformity index of VMAT was 1.22 (1.09-1.45), compared with 1.69 (1.44-2.67) for conventional plans (p = 0.04). The median (range) heterogeneity index was also lower for VMAT compared with conventional plans: 1.04 (1.03-1.07) vs. 1.12 (1.09-1.19), respectively (p = 0.04). A significant reduction of mean and maximum doses was observed in the heart, thyroid, esophagus, optic nerves, and eyes with VMAT when compared with conventional plans. A decrease in body V(10Gy) was observed, but for 4 of 5 patients non-PTV integral dose was increased with VMAT when compared with the conventional plans.
A VMAT technique to treat the craniospinal axis significantly reduces OAR dose, potentially leading to lower late organ toxicity. However, this is achieved at the expense of increased low-dose volumes, which is inherent to the technique, carrying a potentially increased risk of secondary malignancies.
针对颅脊髓照射,开发并比较一种容积调强弧形治疗(VMAT)技术与常规放疗,以提高计划靶区(PTV)的适形度和均匀性,并降低危及器官(OAR)的剂量。
获取了 5 名患者的常规颅脊髓轴放疗计划。PTV 的中位数(范围)长度为 58.9(48.1-83.7)cm。6-MV VMAT 计划在靠近脑部基底的一个等中心点进行逆向计划,并根据指定的脊柱长度,使用最少数量的等中心点。使用高权重优化 PTV 覆盖率和低权重保护 OAR。比较两种方案的适形度和不均匀度指数、剂量-体积直方图、平均剂量和非 PTV 积分剂量(处方剂量为 23.4 Gy,共 13 次)。
VMAT 的中位数(范围)适形度指数为 1.22(1.09-1.45),而常规计划为 1.69(1.44-2.67)(p=0.04)。VMAT 的中位数(范围)不均匀度指数也低于常规计划:1.04(1.03-1.07)与 1.12(1.09-1.19)(p=0.04)。与常规计划相比,VMAT 可显著降低心脏、甲状腺、食管、视神经和眼睛的平均剂量和最大剂量。VMAT 治疗颅脊髓轴时,身体 V(10Gy)减少,但与常规计划相比,4 名患者的非 PTV 积分剂量增加。
VMAT 技术治疗颅脊髓轴可显著降低 OAR 剂量,从而降低晚期器官毒性的风险。然而,这是以增加技术固有低剂量体积为代价的,这可能会增加继发性恶性肿瘤的风险。